SCHEMBL15515355

SCHEMBL15515355

c1cc2cc(N3CCCC3)ccc2o1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PHGDH O43175 1/20 0.47
TERT O14746 3/20 0.46
CYP2A6 P11509 2/20 0.42
DYRK1A Q13627 3/20 0.41
DRD2 P14416 1/20 0.41
DRD3 P35462 1/20 0.41
KCNH2 Q12809 1/20 0.41
MMP2 P08253 1/20 0.41
ADAMTS5 Q9UNA0 1/20 0.41
S100B P04271 2/20 0.41
MEN1 O00255 2/20 0.41
ALDH1A1 P00352 2/20 0.41
MAPT P10636 2/20 0.41
ALOX15 P16050 2/20 0.41
KMT2A Q03164 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
LMNA P02545 1/20 0.41
GAA P10253 1/20 0.41
PKM P14618 1/20 0.41
MAPK1 P28482 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1602312 0.98 TERT (0.47) PHGDHTERTCYP2A6DYRK1ADRD2
SCHEMBL1601529 0.86 MAPT (0.50) PHGDHDRD2DRD3KCNH2MEN1
SCHEMBL29509780 0.84 DYRK1A (0.58) PHGDHDYRK1AHTT
SCHEMBL2548093 0.84 DYRK1A (0.58) PHGDHDYRK1AHTT
SCHEMBL17543405 0.83 PHGDH (0.44) PHGDHCYP2A6DYRK1ADRD2DRD3
SCHEMBL17543425 0.80 PHGDH (0.45) PHGDHCYP2A6DYRK1ADRD2DRD3
SCHEMBL17543417 0.79 LGMN (0.49) PHGDHCYP2A6DYRK1ADRD2DRD3
SCHEMBL2544271 0.77 PHGDH (0.38) PHGDHDYRK1ADRD2DRD3KCNH2
SCHEMBL2544274 0.77 PHGDH (0.42) PHGDHCYP2A6DYRK1ADRD2DRD3
SCHEMBL28841948 0.76 BTK (0.36) PHGDHDYRK1ADRD2DRD3KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2892892-A1 IMIDAZOLIN-5-ONE DERIVATIVES USEFUL AS FATTY ACID SNTHASE (FASN) INHIBITORS FOR!THE TREATMENT OF CANCER Janssen Pharmaceutica N.V. (BE) 2015-07-15 EP disclosed
WO-2014039769-A1 IMIDAZOLIN-5-ONE DERIVATIVES USEFUL AS FATTY ACID SNTHASE (FASN) INHIBITORS FOR|THE TREATMENT OF CANCER JANSSEN PHARMACEUTICA NV (BE) 2014-03-13 WO disclosed